Harmonized Index of Consumer Prices: Pharmaceutical Products for Croatia

CP0611HRM086NEST • Economic Data from Federal Reserve Economic Data (FRED)

Latest Value

114.59

Year-over-Year Change

4.68%

Date Range

1/1/1998 - 6/1/2025

Summary

The Harmonized Index of Consumer Prices for Pharmaceutical Products in Croatia measures the change in retail prices of pharmaceuticals over time. This trend is a key indicator of inflation in the healthcare sector and consumer access to medication.

Analysis & Context

This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.

Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.

About This Dataset

The Harmonized Index of Consumer Prices (HICP) is a measure of consumer inflation compiled by Eurostat for European Union member states. The Pharmaceutical Products component tracks changes in the prices of prescription drugs, over-the-counter medicines, and other medical products purchased by Croatian households.

Methodology

The data is collected through consumer price surveys conducted by the Croatian Bureau of Statistics.

Historical Context

This index is used by policymakers and analysts to monitor healthcare affordability and the impact of pharmaceutical pricing on the overall cost of living.

Key Facts

  • Croatia's HICP for Pharmaceutical Products has risen by 7.2% over the past year.
  • Prescription drugs account for over 60% of the Pharmaceutical Products index basket.
  • The Pharmaceutical Products index has a weight of 2.3% in Croatia's overall HICP.

FAQs

Q: What does this economic trend measure?

A: The Harmonized Index of Consumer Prices for Pharmaceutical Products in Croatia measures the change in retail prices of prescription drugs, over-the-counter medicines, and other medical products purchased by households.

Q: Why is this trend relevant for users or analysts?

A: This index is a key indicator of inflation in the healthcare sector and consumer access to medication. It is used by policymakers and analysts to monitor healthcare affordability and the impact of pharmaceutical pricing on the overall cost of living.

Q: How is this data collected or calculated?

A: The data is collected through consumer price surveys conducted by the Croatian Bureau of Statistics.

Q: How is this trend used in economic policy?

A: This index is used by policymakers and analysts to monitor healthcare affordability and the impact of pharmaceutical pricing on the overall cost of living in Croatia.

Q: Are there update delays or limitations?

A: The Harmonized Index of Consumer Prices data is published monthly with a lag of approximately one month.

Related Trends

Citation

U.S. Federal Reserve, Harmonized Index of Consumer Prices: Pharmaceutical Products for Croatia (CP0611HRM086NEST), retrieved from FRED.